Are there etiology-specific risk factors for adverse outcomes in patients on Impella 5.5 support?
Maigrot JA, Thuita L, Tong MZY, Soltesz EG, Smedira NG, Unai S, Starling RC, Higgins A, Moros D, Blackstone EH, Weiss AJ.
Maigrot JA, et al. Among authors: weiss aj.
JTCVS Open. 2024 Apr 23;21:123-137. doi: 10.1016/j.xjon.2024.04.014. eCollection 2024 Oct.
JTCVS Open. 2024.
PMID: 39534347
Free PMC article.